戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              CMO included only symptom-palliation, whereas nonoperati
2                                              CMO patients had 98% 30-day mortality.
3                                     The 2024 CMO was held in Oceanside, California on February 1 and
4       The layered perovskite Ca(3)Mn(2)O(7) (CMO) is a hybrid improper ferroelectric candidate propos
5  to ordered graphs, we introduce GR-Align, a CMO heuristic that is suited for database searches.
6                                  We report a CMO/carbon composite with low organic contents that perf
7     To investigate how these stresses affect CMO expression, a spinach (Spinacia oleracea L., Chenopo
8                                Shortly after CMO 2019, the coronavirus disease 2019 (COVID-19) pandem
9 or baseline age, phenotype, lens status, and CMO.
10 f magnitude faster than the state-of-the-art CMO solvers Apurva, MSVNS and AlEigen7, and its similari
11  issues that were presented and discussed at CMO and proposes some steps that could be taken to impro
12                         16H5 also attenuated CMO cell proliferation.
13 had aggressive initial management and became CMO following in-hospital complications of their care.
14                             The deduced beet CMO amino acid sequence comprised a transit peptide and
15 ise there was very little similarity between CMO and proteins from plants or other organisms.
16                                 In contrast, CMO homologues are found only in plants and are most clo
17 e analyzed; of these 16 (34%) eyes developed CMO.
18 hemical sensor based on very low-dimensional CMO NPs/GCE using electrochemical reduction phenomena.
19 parous group, 21% had cystoid macular edema (CMO) requiring treatment and 46% had cataracts or were p
20 tters or better); (2) cystoid macular edema (CMO), foveal thickness, and macular volume; (3) developm
21                    Beet roots also expressed CMO, most strongly when salinized.
22 lar to the pivotal trials of aflibercept for CMO secondary to CRVO, which used monthly and then as-ne
23 g reaction step compared to both GaN and GaN@CMO.
24       Moreover, the surface-hydrogenated GaN@CMO-H can significantly lower the reaction energy barrie
25   Consequently, the surface-hydrogenated GaN@CMO-H illustrates a considerable ethylene production act
26  CrMnO(x) is coupled with GaN nanowires (GaN@CMO-H) for light-driven ethanol dehydration to ethylene.
27 ose the ethanol dehydration pathway over GaN@CMO-H.
28  AMI across 827 hospitals, 13 955 (2.9%) had CMO status at discharge (2.6% non-ST-segment-elevation m
29      At 6 months, fewer adjunct patients had CMO (42.7%) or a foveal thickness of >300 mum (47.6%) co
30                There was a modest decline in CMO rates over time (3.0% to 2.8%).
31 with higher VAS scores, whereas increases in CMO (B = -0.011, p < 0.001) were associated with lower V
32 uggests that there is a greater reduction in CMO observed at 6 months in vitrectomized eyes treated w
33           There was substantial variation in CMO rates across hospitals, with the proportion of CMO p
34                       Salinization increased CMO protein levels, apparently via a post-transcriptiona
35                               Salt-inducible CMO mRNA, protein, and enzyme activity were readily dete
36 ., Chenopodiaceae) probe was used to isolate CMO cDNAs from sugar beet (Beta vulgaris L., Chenopodiac
37                                A full-length CMO cDNA (1,622 bp) was cloned from spinach using a prob
38 ncorporation of the human lymphoid cell line CMO, which exhibits constitutive activation of the STAT5
39  initially managed invasively but later made CMO experienced high rates of procedural complications,
40  salinization (NaCl:CaCl2 = 5.7:1, mol/mol), CMO mRNA, protein, and enzyme levels in leaves increased
41                       Choline monooxygenase (CMO) catalyzes the committing step in the synthesis of g
42  step is catalyzed by choline monooxygenase (CMO), a ferredoxin-dependent stromal enzyme that has bee
43 oxide codoped manganese oxide nanoparticles (CMO NPs; dia.
44 sorption ionization MS confirmed that native CMO contains only one type of subunit (Mr 42,864).
45 9 +/- 31 mum at 16 weeks; whereas in the non-CMO group, macular thickness showed a slight increase of
46 o 0.66 +/- 0.41 at week 16; while in the non-CMO group, mean BCVA improved markedly from 0.98 +/- 0.5
47 s of LLS1(PAO), CAO, TIC55 and PTC52 but not CMO are found in the genomes of several cyanobacteria.
48 o report the rate of cystoid macular oedema (CMO) as detected by spectral-domain optical coherence to
49 l of aflibercept for cystoid macular oedema (CMO) secondary to central retinal vein occlusion (CRVO).
50 ntraocular pressure, cystoid macular oedema (CMO), cataract and posterior capsule opacification.
51                               The absence of CMO is the primary constraint on GlyBet production in Gl
52              However, the GlyBet contents of CMO+ plants were very low (0.02-0.05 mumol g-1 fresh wei
53 oblot analyses showed that the expression of CMO in leaves increased several-fold during salinization
54 de (GCE) was fabricated with a thin-layer of CMO NPs by conducting coating binders for the developmen
55 er content declined to 59% and the levels of CMO mRNA, protein, and enzyme activity rose 3- to 5-fold
56 nd hospital-level patterns and predictors of CMO care among patients admitted with AMI.
57  morphological, and structural properties of CMO NPs were characterized in details using FT-IR, UV/vi
58 tes across hospitals, with the proportion of CMO patients ranging from 0% to 17.1% and a median odds
59                         As detection rate of CMO is high, postoperative OCT monitoring for patients w
60 out the prevalence of comfort measures only (CMO) care among patients with AMI.
61 y treatment modality: comfort measures only (CMO), nonoperative treatment, or operative intervention.
62 xt pandemic, the Clinical Microbiology Open (CMO) assembled key stakeholders including directors of c
63              The Clinical Microbiology Open (CMO) is a meeting sponsored by the American Society for
64          The 4th Clinical Microbiology Open (CMO) took place in Carlsbad, California, on 10 and 11 Fe
65 for Microbiology Clinical Microbiology Open (CMO) with various stakeholders to identify potential sol
66                  Clinical Microbiology Open (CMO), a meeting supported by the American Society for Mi
67 ein structures, maximum Contact Map Overlap (CMO) has received sustained attention during the past de
68   A key composition is cobalt (Co)-Mn oxide (CMO) spinel, Co(x)Mn(3-x)O(4), that, despite exemplary p
69 esis is catalyzed by choline mono-oxygenase (CMO), a stromal enzyme with a Rieske-type [2Fe-2S] cente
70 A) between those who developed postoperative CMO against those who did not.
71                   We developed eight realist CMO programme theories.
72                      Forty patients received CMO, 202 underwent nonoperative treatment, and 199 under
73 outcome was meeting the minimum recommended (CMO, UK) 5 x 30 mins moderate physical activity per week
74                         The first and second CMO meetings were held in 2018 and 2019, respectively.
75 plants that constitutively express a spinach CMO cDNA.
76 nthetic method for small, colloidally stable CMO spinel nanocrystals with tunable composition and low
77                             We conclude that CMO is a stress-inducible representative of a new class
78                         These data show that CMO most probably has a mononuclear Fe center, is induci
79                                          The CMO protein was correctly compartmented in chloroplasts
80                                       In the CMO group, mean BCVA (in logarithm of minimum angle of r
81                                       In the CMO group, mean macular thickness (+/-SD) increased shar
82 n on highly sensitive TU sensor based on the CMO NPs/GCE.
83                         Planning for a third CMO is underway and will transition from a discussion-ba
84 d appropriate transition of such patients to CMO, if aligned with their values, remain important area
85 rative efforts discussed during the past two CMO meetings proved critical in addressing the COVID-19
86              Most patients with AMI who were CMO by discharge had aggressive initial management and b
87           Among the 13 955 patients who were CMO by discharge, 8134 (58.3%) underwent diagnostic cath
88                                         When CMO+ plants were supplied in culture with 5 mM choline o
89 aracts or were pseudophakic, versus 18% with CMO and 59% with cataracts in the nulliparous.
90 dent patient characteristics associated with CMO status included male gender, White race, nonprivate
91                         Twenty patients with CMO secondary to CRVO were included in this prospective